Demir, Lutfiye <br/><br/>
Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  2014 
 - 9739-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Standard No.: </label>10.7314/apjcp.2014.15.22.9739  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Cystadenocarcinoma, Serous--metabolism<br/>ErbB Receptors--metabolism<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Ovarian Neoplasms--metabolism<br/>Prognosis<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Retrospective Studies<br/>Survival Rate<br/>Young Adult